Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis

British Journal of Haematology

Volumn 118, Issue 3, 2002, Pages 809-812

  Libra, Massimo ^a,b   De Re, Valli ^a   Gasparotto, Daniela ^a   Gloghini, Annunziata ^a   Marzotto, Alessandra ^a   Milan, Isabella ^a   Tirelli, Umberto ^a   Stivala, Franca ^b   Carbone, Antonino ^a   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

non Hodgkin's lymphoma; Relapse; VDJ

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOPSY; CANCER RECURRENCE; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SECOND CANCER; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; COMPLEMENTARITY DETERMINING REGIONS; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN JOINING REGION; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASMS, SECOND PRIMARY; RECURRENCE; TUMOR STEM CELLS;

EID: 0036041761     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03655.x     Document Type: Article

References (12)

1. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma
2. Les lymphomes non hodgkiniens secondaires
3. Indolent nonfollicular lymphomas: Characteristics, treatment, and outcome
4. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggest that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia
5. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma
6. High-dose therapy for follicular lymphoma
7. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
8. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas
9. A clonally distinct recurrence of Burkitt's Lymphoma at 15 years
10. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
11. High-grade transformation of low-grade non-Hodgkin's lymphomas: Mechanisms of tumor progression
12. Relapsed non-Hodgkin's lymphoma: Detection and treatment